Brokerages Set Silicon Laboratories, Inc. (NASDAQ:SLAB) PT at $151.13

Key Points

• Silicon Laboratories, Inc. has received an average recommendation of "Moderate Buy" from eight analysts, with five suggesting a buy and three advising a hold on the stock.
• The company's recent quarterly report indicated a 32.6% year-over-year increase in revenue, with earnings per share surpassing estimates at $0.11.
• Insider trading activities included SVP Brandon Tolany selling 8,000 shares at an average price of $145.23, reflecting an 11.38% reduction in his holdings.

Shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight analysts that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $151.1250.

A number of equities research analysts have issued reports on the stock. Morgan Stanley cut their price target on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 6th. Barclays raised their price target on shares of Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 5th. Stifel Nicolaus raised their price target on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a report on Friday, July 18th. KeyCorp raised their price target on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an "overweight" rating in a report on Tuesday, July 8th. Finally, Benchmark reissued a "buy" rating and issued a $160.00 price target on shares of Silicon Laboratories in a report on Tuesday, May 27th.

Silicon Laboratories Stock Performance

Shares of SLAB stock traded down $3.10 on Friday, hitting $134.35. 250,212 shares of the company's stock traded hands, compared to its average volume of 384,406. Silicon Laboratories has a one year low of $82.82 and a one year high of $160.00. The company's fifty day simple moving average is $138.84 and its 200 day simple moving average is $127.52. The stock has a market capitalization of $4.41 billion, a price-to-earnings ratio of -41.72 and a beta of 1.48.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. The company had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The firm's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.56) EPS. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. As a group, sell-side analysts anticipate that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.

Insider Buying and Selling at Silicon Laboratories

In other news, SVP Brandon Tolany sold 8,000 shares of Silicon Laboratories stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the sale, the senior vice president owned 62,328 shares of the company's stock, valued at approximately $9,051,895.44. The trade was a 11.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.60% of the company's stock.

Institutional Investors Weigh In On Silicon Laboratories

Large investors have recently modified their holdings of the stock. Quarry LP bought a new stake in shares of Silicon Laboratories during the 1st quarter valued at about $25,000. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Silicon Laboratories during the 1st quarter valued at about $34,000. UMB Bank n.a. boosted its stake in shares of Silicon Laboratories by 111.3% during the 1st quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after purchasing an additional 177 shares in the last quarter. Parallel Advisors LLC boosted its stake in shares of Silicon Laboratories by 143.7% during the 1st quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after purchasing an additional 273 shares in the last quarter. Finally, Larson Financial Group LLC purchased a new stake in shares of Silicon Laboratories in the 1st quarter worth about $55,000.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.